Point Of Care Infectious Disease Testing Market Report 2026
Download Free Sample Buy Now
Point Of Care Infectious Disease Testing Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Point Of Care Infectious Disease Testing Market Report 2026

Global Outlook – By Product (Kits And Reagents, Instruments), By Technology (Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies), By Disease (Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases), By End Use (Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Point Of Care Infectious Disease Testing Market Overview

• Point Of Care Infectious Disease Testing market size has reached to $4.78 billion in 2025

• Expected to grow to $9.02 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%

• Growth Driver: The Rising Contagious Disease Is Fueling The Market Growth Due To The Increasing Need For Rapid Diagnosis And Containment

• Market Trend: The Role Of Proprietary Microfluidic Technology In Diagnostic Advancements

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point Of Care Infectious Disease Testing Market?

Point of care (POC) infectious disease testing refers to diagnostic tests that are performed at or near the site of patient care, such as hospitals, clinics, doctors’ offices, or even at home. These tests are designed to detect infectious diseases quickly and accurately, providing immediate results to facilitate prompt treatment decisions. POC tests are typically user-friendly, require minimal equipment, and offer results within minutes to hours, making them ideal for situations where timely diagnosis is crucial.

The main product types in point of care infectious disease testing are kits and reagents, and instruments. Kits and reagents are pre-prepared components used in point-of-care diagnostics to quickly detect infectious agents through reactions with patient samples. Technologies used include lateral flow immunoassay, agglutination tests, flow-through tests or immunoconcentration assays, and molecular diagnostics, among others, while the diseases tested for include human immunodeficiency virus (HIV), clostridium difficile, hepatitis B virus, pneumonia or streptococcus-associated infections, respiratory syncytial virus, human papillomavirus, influenza, and others. Point-of-care testing is used by various end-users, including hospitals, diagnostic centers, research and academic institutes, homecare settings, and others.

Point Of Care Infectious Disease Testing Market Global Report 2026 Market Report bar graph

What Is The Point Of Care Infectious Disease Testing Market Size and Share 2026?

The point of care infectious disease testing market size has grown rapidly in recent years. It will grow from $4.78 billion in 2025 to $5.44 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to rising incidence of infectious diseases, increased demand for rapid diagnostics, expansion of decentralized healthcare delivery, availability of lateral flow testing technologies, growing use of rapid screening in hospitals.

What Is The Point Of Care Infectious Disease Testing Market Growth Forecast?

The point of care infectious disease testing market size is expected to see rapid growth in the next few years. It will grow to $9.02 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to growing adoption of self-testing solutions, expansion of molecular poc diagnostics, rising investments in digital health integration, increasing focus on outbreak preparedness, growing demand for low-cost rapid tests. Major trends in the forecast period include increasing adoption of rapid molecular poc tests, rising demand for home-based infectious disease testing, growing use of multiplex diagnostic kits, expansion of portable diagnostic instruments, enhanced focus on early disease detection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Point Of Care Infectious Disease Testing Market Segmentation

1) By Product: Kits And Reagents, Instruments

2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies

3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases

4) By End Use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users

Subsegments:

1) By Kits And Reagents: Test Kits, Reagents

2) By Instruments: Portable Devices, Automated Analyzers

What Is The Driver Of The Point Of Care Infectious Disease Testing Market?

The rising contagious disease is expected to propel the growth of the point of care infectious disease testing market going forward. A contagious disease refers to an illness that can be spread from one person to another through direct contact, airborne droplets, or other means of transmission. The rising incidence of contagious diseases is primarily due to increasing human mobility, as greater movement of people across regions and countries facilitates faster and wider transmission of infectious agents. Point of care infectious disease testing accelerates the detection and diagnosis of contagious diseases, enabling timely treatment and reducing the risk of transmission within communities. For instance, in June 2024, according to the UK Health Security Agency, a UK-based government agency, between week 40 of 2022 and week 15 of 2023, 108 NHS trusts in England recorded 1,681 critical care admissions due to confirmed influenza. In contrast, the previous flu season had only 182 admissions across 114 trusts, which increased to 316 by week 39 of 2022. Therefore, the rising contagious disease is driving the growth of point of care infectious disease testing industry.

Key Players In The Global Point Of Care Infectious Disease Testing Market

Major companies operating in the point of care infectious disease testing market are Cardinal Health, F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc., Cepheid Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., GenBody Inc.

Global Point Of Care Infectious Disease Testing Market Trends and Insights

Major companies operating in the point-of-care infectious disease testing market are focusing on integrating innovative technologies such as proprietary microfluidic technology to enhance test accuracy, reduce time-to-results, and improve patient outcomes. Proprietary microfluidic technology refers to specialized systems that manipulate small volumes of fluids at the microscale, enabling rapid, precise, and cost-effective analysis, which helps point of care (POC) infectious disease testing by allowing on-site, fast pathogen detection with integrated sample collection, analysis, and result output, enhancing diagnostic speed and accessibility without the need for centralized laboratory testing. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, launched the PA-100 AST System in Europe, marking the world’s first point-of-care testing solution for directly detecting antimicrobial susceptibility. Utilizing advanced microfluidic technology, the system enables rapid identification of bacterial infections and evaluation of antimicrobial effectiveness, significantly reducing processing time compared to conventional methods. It comprises a compact, desktop-sized analyzer and single-use sample cartridges, making it well-suited for near-patient settings such as primary care clinics. Designed to facilitate faster and more accurate antimicrobial therapy decisions, the system contributes to the global effort to combat antimicrobial resistance by improving diagnostic efficiency.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Point Of Care Infectious Disease Testing Market?

In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired LumiraDx’s point of care technology for $295 million. With this acquisition, Roche aims to expand global access to decentralized diagnostic testing by integrating LumiraDx’s versatile point-of-care platform into its diagnostics portfolio, enabling timely and actionable results across primary care and underserved healthcare settings. LumiraDx is a US-based medical equipment manufacturing company that specializes in providing point of care infectious disease testing.

Regional Outlook

North America was the largest region in the point of care infectious disease testing market in 2025. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Point Of Care Infectious Disease Testing Market?

The point-of-care infectious disease testing market consists of revenues earned by entities by providing services such as rapid diagnostic testing, disease screening, and onsite sample analysis for infectious conditions. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care infectious disease testing market also includes sales of handheld analyzers, lateral flow assays, molecular testing devices, and related consumables used for the immediate detection of infectious diseases. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Point Of Care Infectious Disease Testing Market Report 2026?

The point of care infectious disease testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the point of care infectious disease testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Point Of Care Infectious Disease Testing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $5.44 billion
Revenue Forecast In 2035 $9.02 billion
Growth Rate CAGR of 13.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Technology, Disease, End Use
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Cardinal Health, F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc., Cepheid Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., GenBody Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Point Of Care Infectious Disease Testing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Point Of Care Infectious Disease Testing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Point Of Care Infectious Disease Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Point Of Care Infectious Disease Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Rapid Molecular Poc Tests

4.2.2 Rising Demand For Home-Based Infectious Disease Testing

4.2.3 Growing Use Of Multiplex Diagnostic Kits

4.2.4 Expansion Of Portable Diagnostic Instruments

4.2.5 Enhanced Focus On Early Disease Detection

5. Point Of Care Infectious Disease Testing Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Research And Academic Institutes

5.4 Homecare Settings

5.5 Public Health Laboratories

6. Point Of Care Infectious Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point Of Care Infectious Disease Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Point Of Care Infectious Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Point Of Care Infectious Disease Testing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Point Of Care Infectious Disease Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Point Of Care Infectious Disease Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point Of Care Infectious Disease Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point Of Care Infectious Disease Testing Market Segmentation

9.1. Global Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Kits And Reagents, Instruments

9.2. Global Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies

9.3. Global Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases

9.4. Global Point Of Care Infectious Disease Testing Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users

9.5. Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Test Kits, Reagents

9.6. Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Portable Devices, Automated Analyzers

10. Point Of Care Infectious Disease Testing Market Regional And Country Analysis

10.1. Global Point Of Care Infectious Disease Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Point Of Care Infectious Disease Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point Of Care Infectious Disease Testing Market

11.1. Asia-Pacific Point Of Care Infectious Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point Of Care Infectious Disease Testing Market

12.1. China Point Of Care Infectious Disease Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point Of Care Infectious Disease Testing Market

13.1. India Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point Of Care Infectious Disease Testing Market

14.1. Japan Point Of Care Infectious Disease Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point Of Care Infectious Disease Testing Market

15.1. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point Of Care Infectious Disease Testing Market

16.1. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point Of Care Infectious Disease Testing Market

17.1. South Korea Point Of Care Infectious Disease Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point Of Care Infectious Disease Testing Market

18.1. Taiwan Point Of Care Infectious Disease Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point Of Care Infectious Disease Testing Market

19.1. South East Asia Point Of Care Infectious Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point Of Care Infectious Disease Testing Market

20.1. Western Europe Point Of Care Infectious Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point Of Care Infectious Disease Testing Market

21.1. UK Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point Of Care Infectious Disease Testing Market

22.1. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point Of Care Infectious Disease Testing Market

23.1. France Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point Of Care Infectious Disease Testing Market

24.1. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point Of Care Infectious Disease Testing Market

25.1. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point Of Care Infectious Disease Testing Market

26.1. Eastern Europe Point Of Care Infectious Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point Of Care Infectious Disease Testing Market

27.1. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point Of Care Infectious Disease Testing Market

28.1. North America Point Of Care Infectious Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point Of Care Infectious Disease Testing Market

29.1. USA Point Of Care Infectious Disease Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point Of Care Infectious Disease Testing Market

30.1. Canada Point Of Care Infectious Disease Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point Of Care Infectious Disease Testing Market

31.1. South America Point Of Care Infectious Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point Of Care Infectious Disease Testing Market

32.1. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point Of Care Infectious Disease Testing Market

33.1. Middle East Point Of Care Infectious Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point Of Care Infectious Disease Testing Market

34.1. Africa Point Of Care Infectious Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point Of Care Infectious Disease Testing Market Regulatory and Investment Landscape

36. Point Of Care Infectious Disease Testing Market Competitive Landscape And Company Profiles

36.1. Point Of Care Infectious Disease Testing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Point Of Care Infectious Disease Testing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Point Of Care Infectious Disease Testing Market Company Profiles

36.3.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F Hoffmann La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Point Of Care Infectious Disease Testing Market Other Major And Innovative Companies

Becton Dickinson and Company, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc., Cepheid Inc.

38. Global Point Of Care Infectious Disease Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point Of Care Infectious Disease Testing Market

40. Point Of Care Infectious Disease Testing Market High Potential Countries, Segments and Strategies

40.1 Point Of Care Infectious Disease Testing Market In 2030 - Countries Offering Most New Opportunities

40.2 Point Of Care Infectious Disease Testing Market In 2030 - Segments Offering Most New Opportunities

40.3 Point Of Care Infectious Disease Testing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Point Of Care Infectious Disease Testing Market, Overview Of Key Products - Product Examples
  • Table 2: Global Point Of Care Infectious Disease Testing Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Point Of Care Infectious Disease Testing Market, Supply Chain Analysis
  • Table 4: Global Point Of Care Infectious Disease Testing Market, Major Raw Material Providers
  • Table 5: Global Point Of Care Infectious Disease Testing Market, Major Resource Providers
  • Table 6: Global Point Of Care Infectious Disease Testing Market, Major Manufacturers (Suppliers)
  • Table 7: Global Point Of Care Infectious Disease Testing Market, Major Distributors And Channel Partners
  • Table 8: Global Point Of Care Infectious Disease Testing Market, Key Technologies & Future Trends
  • Table 9: Global Point Of Care Infectious Disease Testing Market, Major Trends
  • Table 10: Global Point Of Care Infectious Disease Testing Market, Major End Users
  • Table 11: Global Point Of Care Infectious Disease Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Point Of Care Infectious Disease Testing Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Point Of Care Infectious Disease Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Point Of Care Infectious Disease Testing Market - TAM, US$ Billion, 2025
  • Table 15: Global Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Point Of Care Infectious Disease Testing Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Point Of Care Infectious Disease Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Point Of Care Infectious Disease Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Point Of Care Infectious Disease Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Point Of Care Infectious Disease Testing Market - Company Scoring Matrix
  • Table 97: Cardinal Health Financial Performance
  • Table 98: F Hoffmann La Roche Ltd Financial Performance
  • Table 99: Thermo Fisher Scientific Inc. Financial Performance
  • Table 100: Abbott Laboratories Financial Performance
  • Table 101: Siemens Healthineers AG Financial Performance
  • Table 102: Global Point Of Care Infectious Disease Testing Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Point Of Care Infectious Disease Testing Market, Competitive Dashboard
  • Table 104: Global Point Of Care Infectious Disease Testing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Point Of Care Infectious Disease Testing Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 106: Global, Point Of Care Infectious Disease Testing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 107: Global, Point Of Care Infectious Disease Testing Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

List Of Figures

    Figure 1: Global Point Of Care Infectious Disease Testing Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Point Of Care Infectious Disease Testing Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Point Of Care Infectious Disease Testing Market, Supply Chain Analysis
  • Figure 4: Global Point Of Care Infectious Disease Testing Market, Major Raw Material Providers
  • Figure 5: Global Point Of Care Infectious Disease Testing Market, Major Resource Providers
  • Figure 6: Global Point Of Care Infectious Disease Testing Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Point Of Care Infectious Disease Testing Market, Major Distributors And Channel Partners
  • Figure 8: Global Point Of Care Infectious Disease Testing Market, Key Technologies & Future Trends
  • Figure 9: Global Point Of Care Infectious Disease Testing Market, Major Trends
  • Figure 10: Global Point Of Care Infectious Disease Testing Market, Major End Users
  • Figure 11: Global Point Of Care Infectious Disease Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Point Of Care Infectious Disease Testing Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Point Of Care Infectious Disease Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Point Of Care Infectious Disease Testing Market - TAM, US$ Billion, 2025
  • Figure 15: Global Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Point Of Care Infectious Disease Testing Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Point Of Care Infectious Disease Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Point Of Care Infectious Disease Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Point Of Care Infectious Disease Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Point Of Care Infectious Disease Testing Market - Company Scoring Matrix
  • Figure 97: Cardinal Health Financial Performance
  • Figure 98: F Hoffmann La Roche Ltd Financial Performance
  • Figure 99: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 100: Abbott Laboratories Financial Performance
  • Figure 101: Siemens Healthineers AG Financial Performance
  • Figure 102: Global Point Of Care Infectious Disease Testing Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Point Of Care Infectious Disease Testing Market, Competitive Dashboard
  • Figure 104: Global Point Of Care Infectious Disease Testing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Point Of Care Infectious Disease Testing Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 106: Global, Point Of Care Infectious Disease Testing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 107: Global, Point Of Care Infectious Disease Testing Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Infectious Disease Diagnostics Testing Market Report 2026 - Global Outlook – By Type (Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test), By Application (Respiratory, Human Immunod...

Point of Care Diagnostics Market Report 2026 - Global Outlook – By Product (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy And Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monito...

Hospital Acquired Infections Testing Kits Market Report 2026 - Global Outlook – By Product (Consumables And Reagents, Instruments), By Test Type (Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infec...

Point-of-Care (POC) Coagulation Testing Market Report 2026 - Global Outlook – By Technology (Optical Technology, Mechanical Technology, Electrochemical Technology), By Distribution Channel (Direct Tenders, Retail), By En...

Antimicrobial Susceptibility Testing Market Report 2026 - Global Outlook – By Testing Type (Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Testing Types), By Product (Manual Antimicrobial Suscept...

Gastrointestinal Pathogen Testing Market Report 2026 - Global Outlook – By Pathogen Type (Bacteria, Viruses, Parasites), By Test Type (Molecular Tests, Culture, Biochemical Tests, Other Test Types), By Panel Type (Syndro...

Hospital-Acquired Infection Control Market Report 2026 - Global Outlook – By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And...

Respiratory Disease Testing Market Report 2026 - Global Outlook – By Test Type (Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests), By Products (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Prod...

Frequently Asked Questions

The Point Of Care Infectious Disease Testing market was valued at $4.78 billion in 2025, increased to $5.44 billion in 2026, and is projected to reach $9.02 billion by 2030.

The global Point Of Care Infectious Disease Testing market is expected to grow at a CAGR of 13.5% from 2026 to 2035 to reach $9.02 billion by 2035.

Some Key Players in the Point Of Care Infectious Disease Testing market Include, Cardinal Health, F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc., Cepheid Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., GenBody Inc. .

Major trend in this market includes: The Role Of Proprietary Microfluidic Technology In Diagnostic Advancements. For further insights on this market. request a sample here

North America was the largest region in the point of care infectious disease testing market in 2025. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us